CLINICAL_TRIALS
trial_result
· 2017-02-27
Clinical Trial Update: Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy [Phase 4]
Summary
Phase 4 trial reports reduction in yellow plaque with aggressive lipid-lowering therapy in coronary artery disease; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Annapoorna Kini | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-02-27